Patent Case Ruling Allows For Launch Of Generic Pepcid Complete
This article was originally published in The Tan Sheet
Executive Summary
The U.S. District Court for the Southern District of New York invalidated a key patent for Johnson & Johnson/Merck's Pepcid Complete, opening the door for Perrigo to enter the market with a private-label equivalent